baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Vanda Pharmaceuticals/ US9216591084 /

6/14/2024 9:59:50 PM	Chg. -0.23	Volume	Bid-	Ask-	High	Low
6.25USD	-3.55%	5,100 Turnover: 32,457.15	-Bid Size: -	-Ask Size: -	6.66	6.23

GlobeNewswire 4/25 Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals

GlobeNewswire 4/19 Butler Hall Capital LLC has issued an open letter to VNDA’s board of directors urging the company to...

GlobeNewswire 3/15 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceut...

GlobeNewswire 10/12/2021 Excision BioTherapeutics Expands Management Team with Three Key Appointments

GlobeNewswire 8/26/2021 iBio Appoints William D. Clark to its Board of Directors

GlobeNewswire 7/23/2021 Notice of Settlement of Derivative Suit

GlobeNewswire 4/25/2021 Lifshitz Law Firm, P.C. Announces Investigations of Jeld-Wen Holding, Inc. (NYSE: JELD), Merit Medic...

GlobeNewswire 4/16/2021 Lifshitz Law Firm, P.C. Announces Investigations of Inovio Pharmaceuticals, Inc. (NasdaqGS: INO), Me...

GlobeNewswire 3/17/2021 SHAREHOLDER ALERT: Barr Law Group Investigating VNDA, VLDR, RIDE, and ABT; Shareholders are Encourag...

GlobeNewswire 11/6/2020 SPS Commerce Announces Appointment of Anne Sempowski Ward to its Board of Directors

GlobeNewswire 10/5/2020 Supernus Pharmaceuticals Appoints James Kelly as Chief Financial Officer

GlobeNewswire 7/8/2020 Atossa Therapeutics Advances Product Development Programs with Multiple Key Hires in Clinical, Regul...

GlobeNewswire 2/3/2020 Cerecor and Aevi Genomic Medicine Complete Merger

GlobeNewswire 1/8/2020 Aclaris Therapeutics Announces Appointment of Vincent Milano to Board of Directors

GlobeNewswire 12/9/2019 InterDigital Appoints Richard Gulino Chief Legal Officer

GlobeNewswire 7/24/2019 Schizophrenia Drugs Markets, 2024 - Leading Players are Alkermes, Bristol-Myers Squibb, Eli Lilly & ...

GlobeNewswire 7/16/2019 SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of ...

GlobeNewswire 5/6/2019 Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019

GlobeNewswire 4/25/2019 CLASS ACTION UPDATE for VNDA, CRCM, ARA and INVVY: Levi & Korsinsky, LLP Reminds Investors of Class ...

GlobeNewswire 4/25/2019 FRIDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Ph...

GlobeNewswire 4/24/2019 Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Vanda Pha...

GlobeNewswire 4/23/2019 VANDA FRIDAY DEADLINE: Rosen Law Firm Reminds Vanda Pharmaceuticals Inc. Investors of Important Apri...

GlobeNewswire 4/22/2019 The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, VNDA, WTW a...

GlobeNewswire 4/18/2019 SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Vanda Pharmac...

GlobeNewswire 4/18/2019 SHAREHOLDER ALERT: VNDA SYNH WSR FSNN: The Law Offices of Vincent Wong Reminds Investors of Importan...

Vanda Pharmaceuticals/ US9216591084 /

If you wish to receive reply to your feedback, please provide your email address.